This white paper takes a deep dive into provider abrasion and unpacks how it could be impacting NCQA Report Card...
Explore our informative 3-part video series, delving into the messaging pillars of Eviti Connect for Oncology. Learn how payers can...
Originally published on Future Healthcare Today Healthcare professionals face numerous challenges as the increasingly dynamic industry evolves through uncertain economic conditions,...
With the median cost of new oncology drugs over $260,000, it’s no wonder payers continue to look for opportunities to...
As the biopharmaceutical industry evolves rapidly, biosimilar products are reshaping the autoimmune treatment paradigm. This comprehensive eBook explores the role...
Oncology innovations and cancer care treatment are complex, exceeding an estimated $200 billion in 2020. As cancer research constantly develops new...
Late Night Health Radio interviews Christina Perkins, VP of Business Insights about tips to ease the burden of prior authorizations...
The burden of cancer and autoimmune diseases is heavy on patients, providers, and payers in the United States. Nearly 40...
There is one common thread that dominates every conversation that we have with healthcare payers and providers — the desire...
True story, I used to love the fax machine at work; I LOVED IT. I was straight out of University...
We are excited about the recent launch of Eviti Connect® for autoimmune diseases, aimed at helping payers and providers realize...
While many payer and provider organizations have found early success with value-based efforts, barriers around data interoperability still prevent the...